Which super funds hold Control Bionics Ltd?
As at 31 December 2025, 15 Australian super investment options in our dataset held Control Bionics Ltd, the largest weighting being 0.00% in Balanced (Accumulation) (CareSuper).
Options holding it
15
Largest weighting
0.00%
Balanced (Accumulation) · CareSuper
Funds & options holding Control Bionics Ltd
Australian super investment options disclosing a holding in Control Bionics Ltd. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| CareSuper | Accumulation | Balanced (Accumulation) | 0.00% | $22,331 | 31 December 2025 |
| CareSuper | Accumulation | Growth (Accumulation) | 0.00% | $3,288 | 31 December 2025 |
| CareSuper | Accumulation | Australian Shares (Accumulation) | 0.00% | $2,297 | 31 December 2025 |
| CareSuper | Retirement | Balanced (Income) | 0.00% | $1,518 | 31 December 2025 |
| CareSuper | Retirement | Conservative Balanced (Income) | 0.00% | $436 | 31 December 2025 |
| CareSuper | Accumulation | Conservative Balanced (Accumulation) | 0.00% | $368 | 31 December 2025 |
| CareSuper | Retirement | Australian Shares (Income) | 0.00% | $288 | 31 December 2025 |
| CareSuper | Retirement | Growth (Income) | 0.00% | $232 | 31 December 2025 |
| CareSuper | Accumulation | Capital Stable (Accumulation) | 0.00% | $197 | 31 December 2025 |
| CareSuper | Retirement | Capital Stable (Income) | 0.00% | $169 | 31 December 2025 |
| CareSuper | Accumulation | Alternative Growth (Accumulation) | 0.00% | $64 | 31 December 2025 |
| CareSuper | Defined benefit | LCC HCC (Defined Benefit) | 0.00% | $35 | 31 December 2025 |
| CareSuper | Retirement | Long Term Pension (Income) | 0.00% | $34 | 31 December 2025 |
| CareSuper | Defined benefit | Quadrant (Defined Benefit) | 0.00% | $15 | 31 December 2025 |
| CareSuper | Retirement | Alternative Growth (Income) | 0.00% | $10 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.